Literature DB >> 2105059

Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium.

D Leszczynski1.   

Abstract

Modulation of the major histocompatibility (MHC) antigen expression on rat endothelial cells by a mixture of cytokines has been examined. Experiments were performed employing both enzyme-linked immunoassay (ELISA) and fluorescence-activated cell-sorting (FACS) techniques and recombinant cytokines: interleukin-1 alpha (IL-1 alpha), tumor necrosis factor alpha (TNF alpha), and gamma-interferon (tau IFN). The results obtained show that TNF alpha enhances the effect of tau IFN on the expression of class I and II MHC antigens. IL-1 alpha did not affect tau IFN-induced class I expression but did inhibit tau IFN-induced class II expression. Finally, TNF alpha-induced class I MHC expression was inhibited strongly by IL-1 alpha. Pretreatment of endothelium with tau IFN did not potentiate the effects of IL-1 alpha or TNF alpha on the endothelial MHC antigen expression. These results suggest a possible anti-inflammatory role of IL-1 alpha via down-regulation of MHC antigen expression by the endothelium.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105059      PMCID: PMC1877470     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  29 in total

1.  Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells.

Authors:  B Ferry; J Halttunen; D Leszczynski; H Schellekens; P H vd Meide; P Häyry
Journal:  Transplantation       Date:  1987-10       Impact factor: 4.939

Review 2.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities.

Authors:  J Le; J Vilcek
Journal:  Lab Invest       Date:  1987-03       Impact factor: 5.662

3.  Renal target structures in acute allograft rejection: a histochemical study.

Authors:  D Leszczynski; M Laszczynska; J Halttunen; P Häyry
Journal:  Kidney Int       Date:  1987-06       Impact factor: 10.612

4.  Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.

Authors:  H Holtmann; D Wallach
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

Review 5.  Eicosanoid production by the coronary microvascular endothelium.

Authors:  M E Gerritsen
Journal:  Fed Proc       Date:  1987-01

Review 6.  Structure-function relationship of tumour necrosis factor and its mechanism of action.

Authors:  W Fiers; P Brouckaert; A L Goldberg; I Kettelhut; P Suffys; J Tavernier; B Vanhaesebroeck; F Van Roy
Journal:  Ciba Found Symp       Date:  1987

7.  Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells.

Authors:  J F Wedgwood; L Hatam; V R Bonagura
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

8.  Tumor necrosis factor enhances interferon-induced Ia antigen expression on murine islet parenchymal cells.

Authors:  J R Wright; H R Epstein; V Hauptfeld; P E Lacy
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

9.  Synergistic effects of recombinant tumour necrosis factor and interferon-gamma on rat thyroid cell growth and Ia antigen expression.

Authors:  A P Weetman; A J Rees
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

10.  Three distinct classes of regulatory cytokines control endothelial cell MHC antigen expression. Interactions with immune gamma interferon differentiate the effects of tumor necrosis factor and lymphotoxin from those of leukocyte alpha and fibroblast beta interferons.

Authors:  L A Lapierre; W Fiers; J S Pober
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  6 in total

1.  Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice.

Authors:  M T Barger; J E Craighead
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 2.  Tumor necrosis factor regulation of major histocompatibility complex gene expression.

Authors:  D R Johnson; J S Pober
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Analysis of T cells and major histocompatibility complex class I and class II mRNA and protein content and distribution in antiglomerular basement membrane disease in the rabbit.

Authors:  C Eldredge; S Merritt; M Goyal; H Kulaga; T J Kindt; R Wiggins
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

4.  Expression of tumor necrosis factor in human acute cardiac rejection. An immunohistochemical and immunoblotting study.

Authors:  E Arbustini; M Grasso; M Diegoli; M Bramerio; A S Foglieni; M Albertario; L Martinelli; A Gavazzi; C Goggi; C Campana
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

5.  Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells.

Authors:  W M Bogers; R K Stad; D J Janssen; N van Rooijen; L A van Es; M R Daha
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

6.  Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.

Authors:  B Crotty; P Hoang; H R Dalton; D P Jewell
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.